Yes, steroids can affect the liver, and the type of steroid determines how. Anabolic steroids, the kind used for muscle building, can cause direct liver damage ranging from mild enzyme elevations to serious structural injury. Corticosteroids, the anti-inflammatory medications prescribed for conditions like asthma or arthritis, affect the liver differently, primarily by promoting fat accumulation. Both categories carry real risks, but the severity depends on the form, dose, and duration of use.
How Anabolic Steroids Damage the Liver
Not all anabolic steroids are equally harmful to the liver. The key factor is a chemical modification called 17-alpha alkylation. This alteration is what makes certain steroids survivable in pill form: it slows the liver’s ability to break them down, so the drug actually reaches the bloodstream after being swallowed. The tradeoff is that the liver is exposed to the compound for much longer than it otherwise would be, and this prolonged contact is what causes damage.
Injectable and gel-based anabolic steroids skip this problem. Because they enter the bloodstream directly through muscle tissue or skin, they don’t need the alkylation modification and don’t linger in the liver the same way. Non-alkylated steroids appear not to be hepatotoxic. This is why, in the rare clinical settings where anabolic steroids are prescribed medically, injection or gel formulations are preferred over oral versions.
Oral anabolic steroids have been linked to four distinct forms of liver injury:
- Transient enzyme elevations: The mildest form. Liver enzymes rise in blood tests, signaling low-grade stress on liver cells. Levels are often only mildly elevated and can return to normal after stopping the drug.
- Cholestasis: Bile flow from the liver slows or stops. This can cause jaundice (yellowing of the skin and eyes), itching, and dark urine.
- Peliosis hepatis: Blood-filled cavities form inside the liver tissue. The liver may become enlarged, deep red, and fragile. Sometimes this causes right-side abdominal pain, but it can also be completely silent, discovered only on an imaging scan or during surgery. In rare cases, the fragile liver tissue ruptures, causing sudden severe abdominal pain and internal bleeding. Peliosis usually reverses, at least partially, after stopping steroid use.
- Liver tumors: Long-term use has been associated with both benign liver growths (adenomas) and, in rare cases, liver cancer. The estimated rate at which benign adenomas transform into cancer is around 4%. Liver cancer linked to anabolic steroid use remains uncommon, with only a handful of documented cases in the medical literature, but it represents the most serious potential outcome.
Why Liver Tests Can Be Misleading
One tricky aspect of steroid-related liver injury is that standard blood tests don’t always catch it. With peliosis hepatis, for example, liver enzyme levels are usually normal or only mildly elevated, even though serious structural damage may be occurring inside the organ. This means a “clean” blood panel doesn’t guarantee the liver is unharmed, particularly with prolonged oral anabolic steroid use. Imaging studies like ultrasound or CT scans are more reliable for detecting conditions like peliosis or tumors.
How Corticosteroids Affect the Liver
Corticosteroids like prednisone and dexamethasone work very differently from anabolic steroids, but they still take a toll on the liver when used at high doses or over long periods. Their primary effect is promoting fatty liver, a condition where triglycerides (fat molecules) accumulate inside liver cells.
This happens through several overlapping pathways. Corticosteroids increase appetite and caloric intake. They raise blood sugar by stimulating the liver to produce more glucose, and some of that excess glucose gets converted right back into fat and stored in the liver. They also trigger the release of fatty acids from fat tissue throughout the body while simultaneously encouraging the liver to absorb those fatty acids. On top of all that, corticosteroids interfere with the liver’s ability to burn fat for energy by suppressing the enzymes responsible for breaking down fatty acids inside mitochondria.
The net result is a liver that’s taking in more fat, making more fat, and burning less fat. Over time, this leads to a buildup of fat-filled droplets in liver cells. While fatty liver can be mild and reversible, sustained fat accumulation raises the risk of inflammation and, eventually, scarring.
Reversibility After Stopping
The good news is that most steroid-related liver effects are reversible once the drug is discontinued. Enzyme elevations typically normalize after dose reduction or stopping therapy. Peliosis hepatis usually improves at least partially. Drug-induced liver injury in general is self-limiting and resolves once the offending medication is removed.
There are important exceptions, though. Liver tumors that have already formed may not fully regress. And stopping corticosteroids abruptly carries its own dangers. In people with underlying hepatitis B, sudden corticosteroid withdrawal can trigger a reactivation of the virus. For those with autoimmune hepatitis, abrupt discontinuation can cause a severe flare. Both situations can be life-threatening, which is why corticosteroids are tapered gradually rather than stopped cold.
Oral vs. Injectable: The Risk Gap
If you’re trying to understand your personal risk, the delivery method matters enormously. Oral anabolic steroids with the 17-alpha alkylation modification carry the highest liver risk by a wide margin. The structural change that makes them effective as pills is, unfortunately, inseparable from the property that makes them toxic to liver cells.
Injectable anabolic steroids bypass the liver on their first pass through the body and don’t require the same chemical modification. They are not free of health risks (cardiovascular and hormonal effects still apply), but they are dramatically less likely to cause the specific forms of liver injury described above. Gel formulations behave similarly to injectables in this regard.
For corticosteroids, the route of administration also matters, but differently. Oral corticosteroids have the most systemic effects, including on the liver. Inhaled corticosteroids (used for asthma) and topical creams deliver much smaller amounts to the bloodstream and are far less likely to cause fatty liver changes. Short courses of oral corticosteroids, such as a five-day prednisone taper for a bad allergic reaction, carry minimal liver risk compared to months or years of daily use.
What Increases the Risk
Several factors amplify how much steroids affect the liver. Duration is the most consistent one: longer use means more cumulative exposure and greater risk of structural damage or tumor development. Higher doses compound this effect. Using multiple oral anabolic steroids simultaneously, a practice called “stacking,” multiplies the liver’s burden.
Pre-existing liver conditions raise the stakes considerably. A liver already dealing with fatty deposits, hepatitis, or alcohol-related damage has less reserve capacity to handle additional stress from steroids. Combining steroid use with heavy alcohol consumption or other liver-toxic substances creates compounding harm that exceeds what either would cause alone.